Target intelligence / Profile preview

Physiological non-heme iron uptake pathways

Molecular classification
Transporter, Receptor, Enzyme
01

Overview

Physiological non-heme iron uptake pathways represent the complex network of proteins and processes responsible for the absorption of inorganic iron from the diet and its distribution to tissues. The primary site of absorption is the duodenum, where ferric iron (Fe3+) is reduced to ferrous iron (Fe2+) by the enzyme duodenal cytochrome B (DCYTB) and then transported across the apical membrane by divalent metal transporter 1 (DMT1) (McKie et al., 2001; Gunshin et al., 1997). Once inside the enterocyte, iron can be stored in ferritin or exported into the bloodstream via ferroportin, the only known mammalian iron exporter (Donovan et al., 2000). This export process is tightly regulated by the hepatic hormone hepcidin, which triggers the internalization and degradation of ferroportin to limit iron availability (Nemeth et al., 2004). In the circulation, iron is carried by transferrin and internalized by cells through transferrin receptor 1 (TfR1)-mediated endocytosis (Klausner et al., 1983). Dysregulation of these pathways leads to significant clinical conditions, such as iron deficiency anemia when uptake is insufficient, or hereditary hemochromatosis when uptake is excessive (Ganz, 2013). Therapeutic strategies targeting these pathways include iron supplementation, chelation therapy, and emerging hepcidin-targeted biologics.

Other names
Non-heme iron absorptionIntestinal iron transportCellular iron acquisitionDietary iron uptake
02

Mechanism of action

Provision of iron substrate for transport, chelation of excess iron, and modulation of the hepcidin-ferroportin axis to regulate iron export.

03

Biological functions

Iron homeostasisMetal ion transportMetabolic process
04

Disease associations

Iron deficiency anemiaHereditary hemochromatosisAnemia of chronic diseaseNeurodegenerative disease
05

Safety considerations

Gastrointestinal toxicitySystemic iron overloadOxidative stressInfection risk from siderophilic bacteriaZinc and copper deficiency
06

Interacting drugs

Ferrous sulfate

5 more in the full profile.

07

Biomarkers

Serum ferritinTransferrin saturationSoluble transferrin receptor (sTfR)HepcidinHemoglobin

Beyond the preview

Go deeper on Physiological non-heme iron uptake pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Physiological non-heme iron uptake pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call